🧬 SinoBioData Academic Portal
Open AccessDOI: 10.3724/abbs.2024211Original Research

Coupling of alternative splicing and alternative polyadenylation

🇨🇳 Original Chinese Title: Coupling of alternative splicing and alternative polyadenylation

Xueying Zhang¹,Feiyan Liu¹,Yu Zhou¹

College of Life Sciences, TaiKang Center for Life and Medical Sciences, Hubei Key Laboratory of Cell Homeostasis, RNA Institute, Wuhan University, Wuhan 430072, China

Read Executive PreviewQuick FAQ
Coupling of alternative splicing and alternative polyadenylation
Graphical Abstract / Figure
Published In
Acta Biochimica et Biophysica Sinica
Published:2025Edition:Vol. 57, Issue 1 • pp. 22-32Citation:Xueying Zhang et al. (2025), Acta Biochimica et Biophysica Sinica
Impact FactorPremier Chinese Biomedical Journal indexed in SinoBioData: Acta Biochimica et Biophysica Sinica (生物化学与生物物理学报).
Sponsored Research Partner

Key Takeaways & Executive Findings

  • • Crosstalk between splicing and 3′-end processing is bidirectional, with each process influencing the other through molecular mechanisms. • 3′-end processing factors and polyA tail promote splicing of the last intron, and can also affect internal and terminal exon splicing. • Splicing within the 3′ UTR contributes to 3′ UTR diversity, and splicing factors can influence 3′-end processing. • Long-read sequencing technologies are crucial for understanding the coordination of AS-APA events and may aid in disease diagnosis and treatment.
Sponsored Research Highlight

Abstract

RNA splicing and 3′-cleavage and polyadenylation (CPA) are essential processes for the maturation of RNA. There have been extensive independent studies of these regulated processing events, including alternative splicing (AS) and alternative polyadenylation (APA). However, growing evidence suggests potential crosstalk between splicing and 3′-end processing in regulating AS or APA. Here, we first provide a brief overview of the molecular machines involved in splicing and 3′-end processing events, and then review recent studies on the functions and mechanisms of the crosstalk between the two processes. On the one hand, 3′-end processing can affect splicing, as 3′-end processing factors and CPA-generated polyA tail promote the splicing of the last intron. Beyond that, 3′-end processing factors can also influence the splicing of internal and terminal exons. Those 3′-end processing factors can also interact with different RNA-binding proteins (RBPs) to exert their effects on AS. The length of 3′ untranslated region (3′ UTR) can affect the splicing of upstream exons. On the other hand, splicing and CPA may compete within introns in generating different products. Furthermore, splicing within the 3′ UTR is a significant factor contributing to 3′ UTR diversity. Splicing also influences 3′-end processing through the actions of certain splicing factors. Interestingly, some classical RBPs play dual roles in both splicing and 3′-end processing. Finally, we discuss how long-read sequencing technologies aid in understanding the coordination of AS-APA events and envision that these findings may potentially promote the development of new strategies for disease diagnosis and treatment.

1. Introduction

In eukaryotes, mRNA synthesis occurs within the cell nucleus, where nascent RNA undergoes a series of processing events to generate mature transcripts, including 5′ capping, splicing, and 3′-end processing. Each of these steps has alternative regulation, such as alternative splicing (AS) in skipping or including an exon and alternative polyadenylation (APA) in selectively choosing proximal or distal polyadenylation site (pPAS or dPAS), or even intronic polyadenylation site (iPAS). These regulatory mechanisms play crucial roles in shaping the final repertoire of mature transcripts, thereby contributing to the complexity of protein isoforms. Hence, both AS and APA contribute significantly to the mRNA diversification and differences in the proteome in many organisms [1,2].

Alternative splicing leads to variations in transcripts through exon skipping, inclusion, intron retention, and etc., determined by the selection of alternative splicing sites [1,3]. Meanwhile, the 3′-end formation in eukaryotes represents a pivotal step in mRNA maturation, involving the recognition of polyadenylation signals and subsequent cleavage and polyadenylation events [2,4]. These two processing events, the majority of which are co-transcriptional, have been studied independently. Contemporary research has revealed an intricate interplay between splicing and 3′-end processing mechanisms [5]. Notably, the coordination of these events is pertinent to APA and AS. This review starts with a brief introduction of the molecular machineries and processes of RNA splicing and 3′-end processing and aims to provide a comprehensive review of the progress on the coupling mechanisms between APA and AS.

SinoBioData Interactive Document Reader
Page 1–5 of Preview
100%
Download Full PDF

Loading authentic research manuscript (Pages 1–5)...

Sponsored Research Partner
Cite This Research Paper
Xueying Zhang, Feiyan Liu, Yu Zhou (2026). Coupling of alternative splicing and alternative polyadenylation. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2024211
SinoBioData Academic & Legal Disclaimer

Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.

Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.

Frequently Asked Questions

What is the main focus of the review?

The review focuses on the coupling mechanisms between alternative splicing (AS) and alternative polyadenylation (APA), highlighting how these two RNA processing events influence each other.

How does 3'-end processing affect splicing?

3'-end processing factors and the polyA tail promote splicing of the last intron, and can also influence splicing of internal and terminal exons through interactions with RNA-binding proteins.

What role does splicing play in 3'-end processing?

Splicing within the 3' UTR contributes to 3' UTR diversity, and certain splicing factors can influence 3'-end processing, indicating a bidirectional crosstalk.

What technologies are discussed for studying AS-APA coordination?

Long-read sequencing technologies are discussed as valuable tools for understanding the coordination of AS-APA events, potentially aiding in disease diagnosis and treatment.

What is the significance of the crosstalk between AS and APA?

The crosstalk between AS and APA expands the complexity of transcriptomes and proteomes, and understanding it may lead to new strategies for disease diagnosis and treatment.

Recommended Scientific Literature & Research Partners

Related Technical Papers & Translations

Research Paper
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.

Read Abstract & PDF
Research Paper
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.

Read Abstract & PDF
Research Paper
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.

Read Abstract & PDF